Putnam BioRevolution ETF
Limited financial coverage for SYNB.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
This exchange-traded fund (ETF) primarily allocates its capital to common equity securities issued by companies globally, irrespective of their market capitalization. Its central investment theme revolves around enterprises driving the "biology revolution," whether they are classified as growth-oriented, value-based, or a blend of both. Periodically, the fund may dedicate a substantial segment of its assets to firms operating within one or more interconnected industries or sectors.
- IPO
- 2022
- HQ
- US
Price Chart
- Market Cap
- $5.29M
- Div Yield
- 0.68%
- 52W High
- $31.73
- 52W Low
- $24.57
- 50D MA
- $30.62
- 200D MA
- $29.10
- Beta
- 1.07
- Avg Volume
- 850
Get TickerSpark's AI analysis on SYNB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SYNB coverage
Recent articles, reports, and earnings notes.
No research on SYNB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SYNB report →Similar companies
Peers in the same neighborhood.